September 14, 2026:

Plus, oral arguments were heard in the landmark abortion pill case Louisiana v. FDA, and abortion rights ballot initiative will be decided by Idaho voters this fall.

Each week, Rewire News Group editors scour headlines nationwide—from lawsuits over abortion access to LGBTQ+ rights—to bring you the most urgent news in reproductive justice. Here’s what you need to know from the past week’s biggest stories.
Indiana’s Supreme Court heard oral arguments last week in a faith-based challenge to the state’s abortion law, which bars abortion except, rarely, in cases like rape or life endangerment. Five women sued in 2022, saying the ban codifies a narrow Christian view that life begins at conception, violating their own religious freedom. Jewish law does not view a fetus as a person; many Islamic and Protestant teachings emphasize personal choice. A lower court ruled for the plaintiffs in March; a new win could spur similar cases.
Louisiana continued its battle to stop mailed mifepristone last week. In its Sept. 9 oral arguments, the state asked the Fifth Circuit Court of Appeals to revoke a 2023 FDA rule allowing the abortion drug to be dispensed by mail or at a pharmacy. Louisiana, which bans abortion, sued the FDA over the rule last year. The Fifth Circuit briefly restricted nationwide access to mifepristone in May, but an emergency order from SCOTUS restored it. The case will likely end up before the Supreme Court.
Idahoans will vote on a reproductive rights initiative in November that would repeal the state’s abortion ban. Last week, the Idaho Supreme Court signed off on revised, Republican-drafted language describing the impacts of picking “yes” or “no” on the measure. The court had rejected GOP leaders’ earlier language as neither clear nor concise, stating that state law does not allow officials to “convey an inaccurate picture of the effect of a specific vote.” Virginia, Nevada, and Missouri will also vote on abortion this fall.
This news roundup is adapted from our newsletter, Rewire Weekly. Sign up here to get the latest reproductive rights news, expert analysis, and a peek into the RNG newsroom—fresh to your inbox.
Source